Margaret Sampson > McDermott Will & Emery LLP > Dallas, United States > Lawyer Profile

McDermott Will & Emery LLP
SUITE 1900
United States
Margaret Sampson photo

Work Department

IP Prosecution


Margaret J. Sampson, Ph.D., focuses her practice on global, strategic intellectual property transactions and patent counseling surrounding the areas of life sciences, pharmaceuticals, research tools and medical devices. Life sciences and technology clients turn to her for evaluating, structuring, negotiating and documenting major transactions.

Margaret’s extensive experience includes advising clients in evaluating patent portfolio positions; analyzing freedom-to-operate issues; identifying and evaluating targets for potential investment, mergers or acquisitions; Hatch-Waxman patent litigation; patent term extensions and adjustments; and patent office proceedings.

She is highly skilled in a variety of transactions such as inbound and outbound licensing and option agreements, development and collaboration agreements, clinical research agreement, clinical and commercial supply agreements, manufacturing agreements, sponsored research agreements, technology transfers, and royalty monetization transactions.

Margaret also has a significant research background, focused on molecular genetics, recombinant DNA and stem cell research, including making mouse knock-out models to better understand the function of genes in an organism.

Lawyer Rankings

United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)

Silicon Valley-based intellectual property head William Gaede, Chicago-based patent prosecution head Ahsan Shaikh, who leads on a number of the team’s prominent matters, and Boston-based IP transactions and licensing head Edward Gordon , are key leaders of the team at McDermott Will & Emery LLP, with Silicon Valley’s Judy Mohr particularly focused on pharmaceutical and medical device matters, developing and defending portfolios for clients in these industries. The team continues to represent major clients such as Meta and related platforms, Panasonic and EA, with Boston’s Jenny Chen and Michael Siekman leading on key matters, an example being the multi-jurisdictional life sciences patent prosecution matter regarding a number of CRISPR Therapeutics’ lead programs. Partner Margaret Sampson notably joined the team in Austin, Texas from Baker Botts L.L.P. in July 2022.